Square Pharmaceuticals’ EPS Rises 21% in First Quarter

Date:

Post View:

Square Pharmaceuticals’ EPS Rises 21% in First Quarter

Square Pharmaceuticals PLC, one of the country’s leading listed pharmaceutical companies, has reported a 21.54% year-on-year increase in earnings per share (EPS) for the first quarter ending September 30, 2025.

The company disclosed its unaudited financial statements for the July–September 2025 quarter following approval by its Board of Directors at a meeting held on Wednesday, November 12.

According to company sources, Square Pharmaceuticals’ consolidated EPS stood at Tk 8.35 for the quarter, compared to Tk 6.87 during the same period last year, reflecting solid growth in earnings.

As of September 30, 2025, the company’s net asset value per share (NAVPS) was reported at Tk 167.50, demonstrating continued financial strength and stability.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_img

Popular

More like this
Related

BGMEA estimates Tk 5,136cr losses from RMG unrest

Ongoing labour unrest in the readymade garment (RMG) sector...

AIBL becomes platinum sponsor of Blue Star team in BCB’s D-3 Trophy

Al-Arafah Islami Bank PLC has signed a Platinum Sponsorship...

Southeast Bank honours 66 employees children for academic excellence

Southeast Bank PLC. has honoured 66 meritorious children of...

Jamuna Bank celebrates completion of entrepreneurship training

Jamuna Bank PLC successfully concluded its month-long (100-hour) Entrepreneurship...